Experimental pharmacokinetics of actoprotective agents: Bromantane and Chlodantane
A. V. Safronenko · 2006 · Candidate of Medical Sciences dissertation. Volgograd, 2006; 124 pages according to catalogue metadata
Study data at a glance
- Participants or experimental model
- Experimental animal tissue-distribution study; human participants not reported.
- Reported results
- The dissertation describes two tissue-exchange groups for Chlodantane: brain, liver, testes, kidneys, lungs and skeletal muscle equilibrated relatively rapidly with plasma, while adipose tissue equilibrated slowly. Bromantane was described using three groups.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- The accessible material is an introduction, conclusions and bibliography transcribed by a third party, not the complete dissertation. Concentration-time tables, half-lives and tissue-specific exposure estimates were not recovered. Occupational-use statements in the introduction concern actoprotectors collectively and do not document a Chlodantane-treated human cohort.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Dissertation abstract transcription
Review depth: Author-abstract transcription: introduction, conclusions and bibliography checked; full dissertation not recovered
Related-report group: safronenko-adamantane-pk-program. Reports in this group are not assumed to be independent trials.
Source access and review scope
Author-abstract transcription: introduction, conclusions and bibliography checked; full dissertation not recovered
Recorded source-check date: 2026-11-01. This date does not imply a completed systematic review.
Source type: Dissertation abstract; third-party transcription
Citation and original source
Original source: A. V. Safronenko. Experimental pharmacokinetics of actoprotective agents: Bromantane and Chlodantane Candidate of Medical Sciences dissertation. Volgograd, 2006; 124 pages according to catalogue metadata 2006.
Molekul research summary: https://molekul.io/research/chlodantane-pk-safronenko-2006. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Chlodantane
N-(adamantan-2-yl)-4-chlorobenzamide, an experimental benzamide from the Russian adamantane program. Its amide linkage distinguishes it from Bromantane’s arylamine.
Bromantane
An adamantane-derived small molecule, also known as Ladasten. The expanded archive connects clinical asthenia studies, operator experiments and preclinical mechanisms, with model-specific limitations and safety findings.